AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figures and large health care icons

Geisinger CMO works to cut friction and lift care

| 7 Min Read
Judge's gavel in movement with a virtual text

Don’t open door to more frivolous medical liability lawsuits

| 5 Min Read
Client at a spa appointment

36 states lack regulatory oversight of med spas

| 6 Min Read
Physician points at tablet

After the survey: Turning physician well-being results into change

| 15 Min Read